Global Ketorolac Tromethamine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 277785
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Ketorolac Tromethamine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Ketorolac Tromethamine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Short-term treatment of pain accounting for % of the Ketorolac Tromethamine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Injection segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Ketorolac Tromethamine include Pfizer, Omeros Corporation, Egalet US Inc., Allergan, and Dr. Reddy’s Laboratories, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Ketorolac Tromethamine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Injection

Ophthalmic

Nasal

Oral tablet

Market segment by Application can be divided into

Short-term treatment of pain

Ophthalmic Surgery

The key market players for global Ketorolac Tromethamine market are listed below:

Pfizer

Omeros Corporation

Egalet US Inc.

Allergan

Dr. Reddy’s Laboratories

Teva

Mylan

West Ward Pharmaceuticals

Fresenius Kabi

Apotex

Sandoz

Amphastar Pharmaceuticals

Gland Pharma Limited

Akorn

Sun Pharmaceutical

Sagent Pharmaceuticals

Aurobindo Pharma

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Ketorolac Tromethamine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Ketorolac Tromethamine, with price, sales, revenue and global market share of Ketorolac Tromethamine from 2019 to 2022.

Chapter 3, the Ketorolac Tromethamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Ketorolac Tromethamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Ketorolac Tromethamine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Ketorolac Tromethamine.

Chapter 13, 14, and 15, to describe Ketorolac Tromethamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Ketorolac Tromethamine Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Ketorolac Tromethamine Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Injection

1.2.3 Ophthalmic

1.2.4 Nasal

1.2.5 Oral tablet

1.3 Market Analysis by Application

1.3.1 Overview: Global Ketorolac Tromethamine Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Short-term treatment of pain

1.3.3 Ophthalmic Surgery

1.4 Global Ketorolac Tromethamine Market Size & Forecast

1.4.1 Global Ketorolac Tromethamine Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Ketorolac Tromethamine Sales in Volume (2017-2028)

1.4.3 Global Ketorolac Tromethamine Price (2017-2028)

1.5 Global Ketorolac Tromethamine Production Capacity Analysis

1.5.1 Global Ketorolac Tromethamine Total Production Capacity (2017-2028)

1.5.2 Global Ketorolac Tromethamine Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Ketorolac Tromethamine Market Drivers

1.6.2 Ketorolac Tromethamine Market Restraints

1.6.3 Ketorolac Tromethamine Trends Analysis

2 Manufacturers Profiles

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Ketorolac Tromethamine Product and Services

2.1.4 Pfizer Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Omeros Corporation

2.2.1 Omeros Corporation Details

2.2.2 Omeros Corporation Major Business

2.2.3 Omeros Corporation Ketorolac Tromethamine Product and Services

2.2.4 Omeros Corporation Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Egalet US Inc.

2.3.1 Egalet US Inc. Details

2.3.2 Egalet US Inc. Major Business

2.3.3 Egalet US Inc. Ketorolac Tromethamine Product and Services

2.3.4 Egalet US Inc. Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Allergan

2.4.1 Allergan Details

2.4.2 Allergan Major Business

2.4.3 Allergan Ketorolac Tromethamine Product and Services

2.4.4 Allergan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Dr. Reddy’s Laboratories

2.5.1 Dr. Reddy’s Laboratories Details

2.5.2 Dr. Reddy’s Laboratories Major Business

2.5.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Product and Services

2.5.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Teva

2.6.1 Teva Details

2.6.2 Teva Major Business

2.6.3 Teva Ketorolac Tromethamine Product and Services

2.6.4 Teva Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Mylan

2.7.1 Mylan Details

2.7.2 Mylan Major Business

2.7.3 Mylan Ketorolac Tromethamine Product and Services

2.7.4 Mylan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 West Ward Pharmaceuticals

2.8.1 West Ward Pharmaceuticals Details

2.8.2 West Ward Pharmaceuticals Major Business

2.8.3 West Ward Pharmaceuticals Ketorolac Tromethamine Product and Services

2.8.4 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9 Fresenius Kabi

2.9.1 Fresenius Kabi Details

2.9.2 Fresenius Kabi Major Business

2.9.3 Fresenius Kabi Ketorolac Tromethamine Product and Services

2.9.4 Fresenius Kabi Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10 Apotex

2.10.1 Apotex Details

2.10.2 Apotex Major Business

2.10.3 Apotex Ketorolac Tromethamine Product and Services

2.10.4 Apotex Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11 Sandoz

2.11.1 Sandoz Details

2.11.2 Sandoz Major Business

2.11.3 Sandoz Ketorolac Tromethamine Product and Services

2.11.4 Sandoz Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12 Amphastar Pharmaceuticals

2.12.1 Amphastar Pharmaceuticals Details

2.12.2 Amphastar Pharmaceuticals Major Business

2.12.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Product and Services

2.12.4 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13 Gland Pharma Limited

2.13.1 Gland Pharma Limited Details

2.13.2 Gland Pharma Limited Major Business

2.13.3 Gland Pharma Limited Ketorolac Tromethamine Product and Services

2.13.4 Gland Pharma Limited Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14 Akorn

2.14.1 Akorn Details

2.14.2 Akorn Major Business

2.14.3 Akorn Ketorolac Tromethamine Product and Services

2.14.4 Akorn Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15 Sun Pharmaceutical

2.15.1 Sun Pharmaceutical Details

2.15.2 Sun Pharmaceutical Major Business

2.15.3 Sun Pharmaceutical Ketorolac Tromethamine Product and Services

2.15.4 Sun Pharmaceutical Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16 Sagent Pharmaceuticals

2.16.1 Sagent Pharmaceuticals Details

2.16.2 Sagent Pharmaceuticals Major Business

2.16.3 Sagent Pharmaceuticals Ketorolac Tromethamine Product and Services

2.16.4 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17 Aurobindo Pharma

2.17.1 Aurobindo Pharma Details

2.17.2 Aurobindo Pharma Major Business

2.17.3 Aurobindo Pharma Ketorolac Tromethamine Product and Services

2.17.4 Aurobindo Pharma Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Ketorolac Tromethamine Breakdown Data by Manufacturer

3 Ketorolac Tromethamine Breakdown Data by Manufacturer

3.1 Global Ketorolac Tromethamine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Ketorolac Tromethamine Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Ketorolac Tromethamine

3.4 Market Concentration Rate

3.4.1 Top 3 Ketorolac Tromethamine Manufacturer Market Share in 2021

3.4.2 Top 6 Ketorolac Tromethamine Manufacturer Market Share in 2021

3.5 Global Ketorolac Tromethamine Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Ketorolac Tromethamine Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4 Market Analysis by Region

4.1 Global Ketorolac Tromethamine Market Size by Region

4.1.1 Global Ketorolac Tromethamine Sales in Volume by Region (2017-2028)

4.1.2 Global Ketorolac Tromethamine Revenue by Region (2017-2028)

4.2 North America Ketorolac Tromethamine Revenue (2017-2028)

4.3 Europe Ketorolac Tromethamine Revenue (2017-2028)

4.4 Asia-Pacific Ketorolac Tromethamine Revenue (2017-2028)

4.5 South America Ketorolac Tromethamine Revenue (2017-2028)

4.6 Middle East and Africa Ketorolac Tromethamine Revenue (2017-2028)

5 Market Segment by Type

5 Market Segment by Type

5.1 Global Ketorolac Tromethamine Sales in Volume by Type (2017-2028)

5.2 Global Ketorolac Tromethamine Revenue by Type (2017-2028)

5.3 Global Ketorolac Tromethamine Price by Type (2017-2028)

6 Market Segment by Application

6 Market Segment by Application

6.1 Global Ketorolac Tromethamine Sales in Volume by Application (2017-2028)

6.2 Global Ketorolac Tromethamine Revenue by Application (2017-2028)

6.3 Global Ketorolac Tromethamine Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7 North America by Country, by Type, and by Application

7.1 North America Ketorolac Tromethamine Sales by Type (2017-2028)

7.2 North America Ketorolac Tromethamine Sales by Application (2017-2028)

7.3 North America Ketorolac Tromethamine Market Size by Country

7.3.1 North America Ketorolac Tromethamine Sales in Volume by Country (2017-2028)

7.3.2 North America Ketorolac Tromethamine Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8 Europe by Country, by Type, and by Application

8.1 Europe Ketorolac Tromethamine Sales by Type (2017-2028)

8.2 Europe Ketorolac Tromethamine Sales by Application (2017-2028)

8.3 Europe Ketorolac Tromethamine Market Size by Country

8.3.1 Europe Ketorolac Tromethamine Sales in Volume by Country (2017-2028)

8.3.2 Europe Ketorolac Tromethamine Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Ketorolac Tromethamine Sales by Type (2017-2028)

9.2 Asia-Pacific Ketorolac Tromethamine Sales by Application (2017-2028)

9.3 Asia-Pacific Ketorolac Tromethamine Market Size by Region

9.3.1 Asia-Pacific Ketorolac Tromethamine Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Ketorolac Tromethamine Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10 South America by Region, by Type, and by Application

10.1 South America Ketorolac Tromethamine Sales by Type (2017-2028)

10.2 South America Ketorolac Tromethamine Sales by Application (2017-2028)

10.3 South America Ketorolac Tromethamine Market Size by Country

10.3.1 South America Ketorolac Tromethamine Sales in Volume by Country (2017-2028)

10.3.2 South America Ketorolac Tromethamine Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Ketorolac Tromethamine Sales by Type (2017-2028)

11.2 Middle East & Africa Ketorolac Tromethamine Sales by Application (2017-2028)

11.3 Middle East & Africa Ketorolac Tromethamine Market Size by Country

11.3.1 Middle East & Africa Ketorolac Tromethamine Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Ketorolac Tromethamine Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12 Raw Material and Industry Chain

12.1 Raw Material of Ketorolac Tromethamine and Key Manufacturers

12.2 Manufacturing Costs Percentage of Ketorolac Tromethamine

12.3 Ketorolac Tromethamine Production Process

12.4 Ketorolac Tromethamine Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Ketorolac Tromethamine Typical Distributors

13.3 Ketorolac Tromethamine Typical Customers

14 Research Findings and Conclusion

14 Research Findings and Conclusion

15 Appendix

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Ketorolac Tromethamine Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Ketorolac Tromethamine Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Pfizer Basic Information, Manufacturing Base and Competitors

Table 4. Pfizer Major Business

Table 5. Pfizer Ketorolac Tromethamine Product and Services

Table 6. Pfizer Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Omeros Corporation Basic Information, Manufacturing Base and Competitors

Table 8. Omeros Corporation Major Business

Table 9. Omeros Corporation Ketorolac Tromethamine Product and Services

Table 10. Omeros Corporation Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Egalet US Inc. Basic Information, Manufacturing Base and Competitors

Table 12. Egalet US Inc. Major Business

Table 13. Egalet US Inc. Ketorolac Tromethamine Product and Services

Table 14. Egalet US Inc. Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Allergan Basic Information, Manufacturing Base and Competitors

Table 16. Allergan Major Business

Table 17. Allergan Ketorolac Tromethamine Product and Services

Table 18. Allergan Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors

Table 20. Dr. Reddy’s Laboratories Major Business

Table 21. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product and Services

Table 22. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Teva Basic Information, Manufacturing Base and Competitors

Table 24. Teva Major Business

Table 25. Teva Ketorolac Tromethamine Product and Services

Table 26. Teva Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Mylan Basic Information, Manufacturing Base and Competitors

Table 28. Mylan Major Business

Table 29. Mylan Ketorolac Tromethamine Product and Services

Table 30. Mylan Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. West Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 32. West Ward Pharmaceuticals Major Business

Table 33. West Ward Pharmaceuticals Ketorolac Tromethamine Product and Services

Table 34. West Ward Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. Fresenius Kabi Basic Information, Manufacturing Base and Competitors

Table 36. Fresenius Kabi Major Business

Table 37. Fresenius Kabi Ketorolac Tromethamine Product and Services

Table 38. Fresenius Kabi Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 39. Apotex Basic Information, Manufacturing Base and Competitors

Table 40. Apotex Major Business

Table 41. Apotex Ketorolac Tromethamine Product and Services

Table 42. Apotex Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 43. Sandoz Basic Information, Manufacturing Base and Competitors

Table 44. Sandoz Major Business

Table 45. Sandoz Ketorolac Tromethamine Product and Services

Table 46. Sandoz Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 47. Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 48. Amphastar Pharmaceuticals Major Business

Table 49. Amphastar Pharmaceuticals Ketorolac Tromethamine Product and Services

Table 50. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 51. Gland Pharma Limited Basic Information, Manufacturing Base and Competitors

Table 52. Gland Pharma Limited Major Business

Table 53. Gland Pharma Limited Ketorolac Tromethamine Product and Services

Table 54. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 55. Akorn Basic Information, Manufacturing Base and Competitors

Table 56. Akorn Major Business

Table 57. Akorn Ketorolac Tromethamine Product and Services

Table 58. Akorn Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 59. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 60. Sun Pharmaceutical Major Business

Table 61. Sun Pharmaceutical Ketorolac Tromethamine Product and Services

Table 62. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 63. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 64. Sagent Pharmaceuticals Major Business

Table 65. Sagent Pharmaceuticals Ketorolac Tromethamine Product and Services

Table 66. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 67. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors

Table 68. Aurobindo Pharma Major Business

Table 69. Aurobindo Pharma Ketorolac Tromethamine Product and Services

Table 70. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 71. Global Ketorolac Tromethamine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)

Table 72. Global Ketorolac Tromethamine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 73. Market Position of Manufacturers in Ketorolac Tromethamine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 74. Global Ketorolac Tromethamine Production Capacity by Company, (K Units): 2020 VS 2021

Table 75. Head Office and Ketorolac Tromethamine Production Site of Key Manufacturer

Table 76. Ketorolac Tromethamine New Entrant and Capacity Expansion Plans

Table 77. Ketorolac Tromethamine Mergers & Acquisitions in the Past Five Years

Table 78. Global Ketorolac Tromethamine Sales by Region (2017-2022) & (K Units)

Table 79. Global Ketorolac Tromethamine Sales by Region (2023-2028) & (K Units)

Table 80. Global Ketorolac Tromethamine Revenue by Region (2017-2022) & (USD Million)

Table 81. Global Ketorolac Tromethamine Revenue by Region (2023-2028) & (USD Million)

Table 82. Global Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)

Table 83. Global Ketorolac Tromethamine Sales by Type (2023-2028) & (K Units)

Table 84. Global Ketorolac Tromethamine Revenue by Type (2017-2022) & (USD Million)

Table 85. Global Ketorolac Tromethamine Revenue by Type (2023-2028) & (USD Million)

Table 86. Global Ketorolac Tromethamine Price by Type (2017-2022) & (USD/Unit)

Table 87. Global Ketorolac Tromethamine Price by Type (2023-2028) & (USD/Unit)

Table 88. Global Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)

Table 89. Global Ketorolac Tromethamine Sales by Application (2023-2028) & (K Units)

Table 90. Global Ketorolac Tromethamine Revenue by Application (2017-2022) & (USD Million)

Table 91. Global Ketorolac Tromethamine Revenue by Application (2023-2028) & (USD Million)

Table 92. Global Ketorolac Tromethamine Price by Application (2017-2022) & (USD/Unit)

Table 93. Global Ketorolac Tromethamine Price by Application (2023-2028) & (USD/Unit)

Table 94. North America Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units)

Table 95. North America Ketorolac Tromethamine Sales by Country (2023-2028) & (K Units)

Table 96. North America Ketorolac Tromethamine Revenue by Country (2017-2022) & (USD Million)

Table 97. North America Ketorolac Tromethamine Revenue by Country (2023-2028) & (USD Million)

Table 98. North America Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)

Table 99. North America Ketorolac Tromethamine Sales by Type (2023-2028) & (K Units)

Table 100. North America Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)

Table 101. North America Ketorolac Tromethamine Sales by Application (2023-2028) & (K Units)

Table 102. Europe Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units)

Table 103. Europe Ketorolac Tromethamine Sales by Country (2023-2028) & (K Units)

Table 104. Europe Ketorolac Tromethamine Revenue by Country (2017-2022) & (USD Million)

Table 105. Europe Ketorolac Tromethamine Revenue by Country (2023-2028) & (USD Million)

Table 106. Europe Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)

Table 107. Europe Ketorolac Tromethamine Sales by Type (2023-2028) & (K Units)

Table 108. Europe Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)

Table 109. Europe Ketorolac Tromethamine Sales by Application (2023-2028) & (K Units)

Table 110. Asia-Pacific Ketorolac Tromethamine Sales by Region (2017-2022) & (K Units)

Table 111. Asia-Pacific Ketorolac Tromethamine Sales by Region (2023-2028) & (K Units)

Table 112. Asia-Pacific Ketorolac Tromethamine Revenue by Region (2017-2022) & (USD Million)

Table 113. Asia-Pacific Ketorolac Tromethamine Revenue by Region (2023-2028) & (USD Million)

Table 114. Asia-Pacific Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)

Table 115. Asia-Pacific Ketorolac Tromethamine Sales by Type (2023-2028) & (K Units)

Table 116. Asia-Pacific Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)

Table 117. Asia-Pacific Ketorolac Tromethamine Sales by Application (2023-2028) & (K Units)

Table 118. South America Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units)

Table 119. South America Ketorolac Tromethamine Sales by Country (2023-2028) & (K Units)

Table 120. South America Ketorolac Tromethamine Revenue by Country (2017-2022) & (USD Million)

Table 121. South America Ketorolac Tromethamine Revenue by Country (2023-2028) & (USD Million)

Table 122. South America Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)

Table 123. South America Ketorolac Tromethamine Sales by Type (2023-2028) & (K Units)

Table 124. South America Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)

Table 125. South America Ketorolac Tromethamine Sales by Application (2023-2028) & (K Units)

Table 126. Middle East & Africa Ketorolac Tromethamine Sales by Region (2017-2022) & (K Units)

Table 127. Middle East & Africa Ketorolac Tromethamine Sales by Region (2023-2028) & (K Units)

Table 128. Middle East & Africa Ketorolac Tromethamine Revenue by Region (2017-2022) & (USD Million)

Table 129. Middle East & Africa Ketorolac Tromethamine Revenue by Region (2023-2028) & (USD Million)

Table 130. Middle East & Africa Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)

Table 131. Middle East & Africa Ketorolac Tromethamine Sales by Type (2023-2028) & (K Units)

Table 132. Middle East & Africa Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)

Table 133. Middle East & Africa Ketorolac Tromethamine Sales by Application (2023-2028) & (K Units)

Table 134. Ketorolac Tromethamine Raw Material

Table 135. Key Manufacturers of Ketorolac Tromethamine Raw Materials

Table 136. Direct Channel Pros & Cons

Table 137. Indirect Channel Pros & Cons

Table 138. Ketorolac Tromethamine Typical Distributors

Table 139. Ketorolac Tromethamine Typical Customers

List of Figures

Figure 1. Ketorolac Tromethamine Picture

Figure 2. Global Ketorolac Tromethamine Revenue Market Share by Type in 2021

Figure 3. Injection

Figure 4. Ophthalmic

Figure 5. Nasal

Figure 6. Oral tablet

Figure 7. Global Ketorolac Tromethamine Revenue Market Share by Application in 2021

Figure 8. Short-term treatment of pain

Figure 9. Ophthalmic Surgery

Figure 10. Global Ketorolac Tromethamine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028

Figure 11. Global Ketorolac Tromethamine Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Ketorolac Tromethamine Sales (2017-2028) & (K Units)

Figure 13. Global Ketorolac Tromethamine Price (2017-2028) & (USD/Unit)

Figure 14. Global Ketorolac Tromethamine Production Capacity (2017-2028) & (K Units)

Figure 15. Global Ketorolac Tromethamine Production Capacity by Geographic Region: 2022 VS 2028

Figure 16. Ketorolac Tromethamine Market Drivers

Figure 17. Ketorolac Tromethamine Market Restraints

Figure 18. Ketorolac Tromethamine Market Trends

Figure 19. Global Ketorolac Tromethamine Sales Market Share by Manufacturer in 2021

Figure 20. Global Ketorolac Tromethamine Revenue Market Share by Manufacturer in 2021

Figure 21. Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 22. Top 3 Ketorolac Tromethamine Manufacturer (Revenue) Market Share in 2021

Figure 23. Top 6 Ketorolac Tromethamine Manufacturer (Revenue) Market Share in 2021

Figure 24. Global Ketorolac Tromethamine Sales Market Share by Region (2017-2028)

Figure 25. Global Ketorolac Tromethamine Revenue Market Share by Region (2017-2028)

Figure 26. North America Ketorolac Tromethamine Revenue (2017-2028) & (USD Million)

Figure 27. Europe Ketorolac Tromethamine Revenue (2017-2028) & (USD Million)

Figure 28. Asia-Pacific Ketorolac Tromethamine Revenue (2017-2028) & (USD Million)

Figure 29. South America Ketorolac Tromethamine Revenue (2017-2028) & (USD Million)

Figure 30. Middle East & Africa Ketorolac Tromethamine Revenue (2017-2028) & (USD Million)

Figure 31. Global Ketorolac Tromethamine Sales Market Share by Type (2017-2028)

Figure 32. Global Ketorolac Tromethamine Revenue Market Share by Type (2017-2028)

Figure 33. Global Ketorolac Tromethamine Price by Type (2017-2028) & (USD/Unit)

Figure 34. Global Ketorolac Tromethamine Sales Market Share by Application (2017-2028)

Figure 35. Global Ketorolac Tromethamine Revenue Market Share by Application (2017-2028)

Figure 36. Global Ketorolac Tromethamine Price by Application (2017-2028) & (USD/Unit)

Figure 37. North America Ketorolac Tromethamine Sales Market Share by Type (2017-2028)

Figure 38. North America Ketorolac Tromethamine Sales Market Share by Application (2017-2028)

Figure 39. North America Ketorolac Tromethamine Sales Market Share by Country (2017-2028)

Figure 40. North America Ketorolac Tromethamine Revenue Market Share by Country (2017-2028)

Figure 41. United States Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Canada Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Mexico Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Europe Ketorolac Tromethamine Sales Market Share by Type (2017-2028)

Figure 45. Europe Ketorolac Tromethamine Sales Market Share by Application (2017-2028)

Figure 46. Europe Ketorolac Tromethamine Sales Market Share by Country (2017-2028)

Figure 47. Europe Ketorolac Tromethamine Revenue Market Share by Country (2017-2028)

Figure 48. Germany Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. France Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. United Kingdom Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Russia Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Italy Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Asia-Pacific Ketorolac Tromethamine Sales Market Share by Region (2017-2028)

Figure 54. Asia-Pacific Ketorolac Tromethamine Sales Market Share by Application (2017-2028)

Figure 55. Asia-Pacific Ketorolac Tromethamine Sales Market Share by Region (2017-2028)

Figure 56. Asia-Pacific Ketorolac Tromethamine Revenue Market Share by Region (2017-2028)

Figure 57. China Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Japan Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Korea Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. India Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Southeast Asia Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Australia Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South America Ketorolac Tromethamine Sales Market Share by Type (2017-2028)

Figure 64. South America Ketorolac Tromethamine Sales Market Share by Application (2017-2028)

Figure 65. South America Ketorolac Tromethamine Sales Market Share by Country (2017-2028)

Figure 66. South America Ketorolac Tromethamine Revenue Market Share by Country (2017-2028)

Figure 67. Brazil Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Argentina Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Type (2017-2028)

Figure 70. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Application (2017-2028)

Figure 71. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Region (2017-2028)

Figure 72. Middle East & Africa Ketorolac Tromethamine Revenue Market Share by Region (2017-2028)

Figure 73. Turkey Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Egypt Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South Africa Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Manufacturing Cost Structure Analysis of Ketorolac Tromethamine in 2021

Figure 78. Manufacturing Process Analysis of Ketorolac Tromethamine

Figure 79. Ketorolac Tromethamine Industrial Chain

Figure 80. Sales Channel: Direct Channel vs Indirect Channel

Figure 81. Methodology

Figure 82. Research Process and Data Source